BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25113439)

  • 1. Regulatory T cells with CD62L or TNFR2 expression in young type 1 diabetic patients: relation to inflammation, glycemic control and micro-vascular complications.
    El-Samahy MH; Adly AA; Ismail EA; Salah NY
    J Diabetes Complications; 2015; 29(1):120-6. PubMed ID: 25113439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Regulatory T lymphocytes expressing L-selectin in children and adolescents with type 1 diabetes mellitus].
    Ryba M; Hak L; Zorena K; Myśliwiec M; Myśliwska J
    Pediatr Endocrinol Diabetes Metab; 2010; 16(1):12-6. PubMed ID: 20529600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower frequency of CD62L(high) and higher frequency of TNFR2(+) Tregs are associated with inflammatory conditions in type 1 diabetic patients.
    Ryba M; Rybarczyk-Kapturska K; Zorena K; Myśliwiec M; Myśliwska J
    Mediators Inflamm; 2011; 2011():645643. PubMed ID: 21584225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Regulatory T Cells in Peripheral Blood of Acute Myeloid Leukemia Patients Rely on Tumor Necrosis Factor (TNF)-α-TNF Receptor-2 Pathway.
    Wang M; Zhang C; Tian T; Zhang T; Wang R; Han F; Zhong C; Hua M; Ma D
    Front Immunol; 2018; 9():1274. PubMed ID: 29922294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets microparticles as a link between micro- and macro-angiopathy in young patients with type 1 diabetes.
    Salem MA; Adly AA; Ismail EA; Darwish YW; Kamel HA
    Platelets; 2015; 26(7):682-8. PubMed ID: 25806426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial monocyte activating polypeptide II in children and adolescents with type 1 diabetes mellitus: Relation to micro-vascular complications.
    Adly AAM; Ismail EA; Tawfik LM; Ebeid FSE; Hassan AAS
    Cytokine; 2015 Dec; 76(2):156-162. PubMed ID: 26142824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing TNF receptor 2+ regulatory T cells via the combined action of azacitidine and the HDAC inhibitor, panobinostat for clinical benefit in acute myeloid leukemia patients.
    Govindaraj C; Tan P; Walker P; Wei A; Spencer A; Plebanski M
    Clin Cancer Res; 2014 Feb; 20(3):724-35. PubMed ID: 24297862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Could the expression of L-selectin be an early marker of arterial hypertension and microangiopathy in the course of type 1 diabetes mellitus in juvenile patients?].
    Pawłowski P; Urban M; Peczyńska J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):147-52. PubMed ID: 16232368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of TNFR2 by regulatory T cells in peripheral blood is correlated with clinical pathology of lung cancer patients.
    Yan F; Du R; Wei F; Zhao H; Yu J; Wang C; Zhan Z; Ding T; Ren X; Chen X; Li H
    Cancer Immunol Immunother; 2015 Nov; 64(11):1475-85. PubMed ID: 26280204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Significance of Tumor Necrosis Factor Receptor Type II in CD8
    Ye LL; Wei XS; Zhang M; Niu YR; Zhou Q
    Front Immunol; 2018; 9():583. PubMed ID: 29623079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.
    Targher G; Bertolini L; Zoppini G; Zenari L; Falezza G
    Diabet Med; 2005 Aug; 22(8):999-1004. PubMed ID: 16026364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of serum IL-12 and IL-18 are associated with lower frequencies of CD4(+)CD25 (high)FOXP3 (+) regulatory t cells in young patients with type 1 diabetes.
    Ryba-Stanisławowska M; Rybarczyk-Kapturska K; Myśliwiec M; Myśliwska J
    Inflammation; 2014 Oct; 37(5):1513-20. PubMed ID: 24677179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells.
    Kampan NC; Madondo MT; McNally OM; Stephens AN; Quinn MA; Plebanski M
    Front Immunol; 2017; 8():1482. PubMed ID: 29163543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab therapy balances regulatory T cells, tumour necrosis factor receptor 2 (TNFR2) expression and soluble TNFR2 in sarcoidosis.
    Verwoerd A; Hijdra D; Vorselaars AD; Crommelin HA; van Moorsel CH; Grutters JC; Claessen AM
    Clin Exp Immunol; 2016 Aug; 185(2):263-70. PubMed ID: 27158798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant frequency of TNFR2-expressing CD4+ FoxP3+ regulatory T cells in nasopharyngeal carcinoma patients.
    Engku Abd Rahman ENS; Irekeola AA; Shueb RH; Mat Lazim N; Mohamud R; Chen X; Ghazali L; Awang NMSH; Haron A; Chan YY
    Cytokine; 2023 Oct; 170():156341. PubMed ID: 37657236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lenalidomide-based maintenance therapy reduces TNF receptor 2 on CD4 T cells and enhances immune effector function in acute myeloid leukemia patients.
    Govindaraj C; Madondo M; Kong YY; Tan P; Wei A; Plebanski M
    Am J Hematol; 2014 Aug; 89(8):795-802. PubMed ID: 24757092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF optimally activatives regulatory T cells by inducing TNF receptor superfamily members TNFR2, 4-1BB and OX40.
    Hamano R; Huang J; Yoshimura T; Oppenheim JJ; Chen X
    Eur J Immunol; 2011 Jul; 41(7):2010-20. PubMed ID: 21491419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines and T regulatory cells in the pathogenesis of type 1 diabetes.
    Kikodze N; Pantsulaia I; Rekhviashvili Kh; Iobadze M; Dzhakhutashvili N; Pantsulaia N; Kukuladze N; Bikashvili N; Metreveli D; Chikovani T
    Georgian Med News; 2013 Sep; (222):29-35. PubMed ID: 24099812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+ Tregs within the tumor microenvironment.
    Govindaraj C; Scalzo-Inguanti K; Madondo M; Hallo J; Flanagan K; Quinn M; Plebanski M
    Clin Immunol; 2013 Oct; 149(1):97-110. PubMed ID: 23948613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of TNF-α/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer.
    Qu Y; Wang X; Bai S; Niu L; Zhao G; Yao Y; Li B; Li H
    Int J Cancer; 2022 Apr; 150(8):1373-1391. PubMed ID: 34766338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.